Retroviral intasome assembly and inhibition of DNA strand transfer
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Integrase is an essential retroviral enzyme that binds both termini of linear viral DNA and inserts them into a host cell chromosome. The structure of full-length retroviral integrase, either separately or in complex with DNA, has been lacking. Furthermore, although clinically useful inhibitors of HIV integrase have been developed, their mechanism of action remains speculative. Here we present a crystal structure of full-length integrase from the prototype foamy virus in complex with its cognate DNA. The structure shows the organization of the retroviral intasome comprising an integrase tetramer tightly associated with a pair of viral DNA ends. All three canonical integrase structural domains are involved in extensive protein-DNA and protein-protein interactions. The binding of strand-transfer inhibitors displaces the reactive viral DNA end from the active site, disarming the viral nucleoprotein complex. Our findings define the structural basis of retroviral DNA integration, and will allow modelling of the HIV-1 intasome to aid in the development of antiretroviral drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The structures revealed unexpected architectural diversity among intasomes from different retroviral genera.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with their function, all intasomes feature 2-fold symmetry and harbour a pair of juxtaposed active sites engaged with 3’ vDNA ends.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Within the CIC, the IN dimers are bridged via the exchange of associated NTDs and are joined by a pair of CTDs (referred to as the synaptic CTDs), which act as rigid spacers.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the intasomes from the prototype foamy virus (PFV, a simiispumavirus) as well as the δ-retroviruses HTLV-1 and simian T-cell lymphotropic virus (STLV) contain four IN subunits (arranged as a dimer-of-dimers)25,29,37,38”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite these differences, all intasomes incorporate the conserved intasome core (CIC) assembly, which is the minimal functional unit and is represented by the PFV structure (Figs. 2A, 3).”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
The interpretation of protein structures: Estimation of static accessibility
Lee, B., & Richards, F. M. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90324-x · Cited by 5,850
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,804
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,896
The Buccaneer software for automated model building. 1. Tracing protein chains
Cowtan, K. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906022116 · Cited by 1,822
Use of TLS parameters to model anisotropic displacements in macromolecular refinement
Winn, M. D., Isupov, M. N., & Murshudov, G. N. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444900014736 · Cited by 1,696
Gouet, P. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg556 · Cited by 1,509
Research works printed but not linked: 2
- Grobler, J. A., Stillmock, K., Miller, M. D. & Hazuda, D. J. Mechanism by which the HIV integrase active-site mutation N155H confers resistance to raltegravir. Antivir. Ther. 13 (suppl. 3). A41 (2008)
- Leslie, A. G. W. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 and ESF-EAMCB Newsletter on Protein Crystallography no. 26, (1992)
Cited by
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Nucleases: diversity of structure, function and mechanism
Yang, W. (2011) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583510000181 · Cited by 692
The structural biology of HIV-1: mechanistic and therapeutic insights
Engelman, A., & Cherepanov, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2747 · Cited by 424
“Recent successes are due to the application of X-ray crystallography to the tractable intasome of the prototype foamy virus (PFV), a member of the retroviral genus Spumaviru”
BackgroundSelf-citationCraigie, R., & Bushman, F. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006890 · Cited by 327
“Determination of the structure of prototype foamy virus (PFV) IN in complex with viral DNA (Hare et al. 2010; Maertens et al. 2010) provided a major breakthrough in understanding IN function.”
BackgroundMolecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance
Hare, S., Vos, A. M., Clayton, R. F., Thuring, J. W., Cummings, M. D., & Cherepanov, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010246107 · Cited by 305
“Consistent with our previous results (6), the INSTIs bind to the active site, displacing the 3′-hydroxyl group (and indeed the entire 3′terminal nucleotide of viral DNA) and thereby inactivating the intasome (Fig.”
BackgroundMethodResultInfluentialSelf-citationThe mechanism of retroviral integration from X-ray structures of its key intermediates
Maertens, G. N., Hare, S., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature09517 · Cited by 296
Self-citationHare, S., Smith, S. J., Métifiot, M., Jaxa-Chamiec, A., Pommier, Y., Hughes, S. H., & Cherepanov, P. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073189 · Cited by 264
“Our previous S217H and N224H intasome structures obtained in the presence and absence of MK-2048 showed that these amino acid substitutions cause subtle shifts in active site geometry and that binding of the INSTI causes remodeling of the mutant active sites (Hare et al., 2010b).”
BackgroundMethodInfluentialSelf-citationInterfacial inhibitors: targeting macromolecular complexes
Pommier, Y., & Marchand, C. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3404 · Cited by 259
“Stunning co-crystal structures of integrase with its viral substrates have revealed the trapping of the integrase–DNA complex as the drugs bind at its interfac”
Reguera, J., Weber, F., & Cusack, S. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001101 · Cited by 255
Quashie, P. K., Mesplède, T., Han, Y.-S., Oliveira, M., Singhroy, D. N., Fujiwara, T., Underwood, M. R., & Wainberg, M. A. (2012) · Journal of Virology · doi:10.1128/jvi.06591-11 · Cited by 237
“Accordingly, we used Protein Data Bank (PDB) identification numbers 3L2R (26), 3S3M (27), and 3OS0 (39) as starting points for structural refinement of wild-type and R263K intasomes, drug-bound intasome, and STC, respectively.”
BackgroundMethodInfluentialLesbats, P., Engelman, A. N., & Cherepanov, P. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00125 · Cited by 233
Self-citationHightower, K. E., Wang, R., DeAnda, F., Johns, B. A., Weaver, K., Shen, Y., Tomberlin, G. H., Carter, H. L., Broderick, T., Sigethy, S., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00157-11 · Cited by 226
HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
Blanco, J.-L., Varghese, V., Rhee, S.-Y., Gatell, J. M., & Shafer, R. W. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir025 · Cited by 218
“But the relative conformation of the CCD, NTD, and CTD domains and the tetrameric state of functional HIV-1 IN has been inferred primarily from crystallographic studies of the homologous IN of the prototype foamy virus (PFV) [5].”
BackgroundMenéndez-Arias, L. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.01.007 · Cited by 207
Jurado, K. A., Wang, H., Slaughter, A., Feng, L., Kessl, J. J., Koh, Y., Wang, W., Ballandras-Colas, A., Patel, P. A., Fuchs, J. R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300703110 · Cited by 203
“FLAG-tagged HIV-1NL4-3-based bacterial integrase (IN) expression vector was described previously (3); pCPH6PHIV1-IN (4) was used to express hexahistidine (His6) tagged HIV-1HXB2-based IN.”
BackgroundMethodInfluentialSelf-citationCryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome
Passos, D. O., Li, M., Yang, R., Rebensburg, S. V., Ghirlando, R., Jeon, Y., Shkriabai, N., Kvaratskhelia, M., Craigie, R., & Lyumkis, D. (2017) · Science · doi:10.1126/science.aah5163 · Cited by 202
“In this regard, the structure of the PFV intasome (9, 10) presented a conundrum.”
BackgroundBET proteins promote efficient murine leukemia virus integration at transcription start sites
Sharma, A., Larue, R. C., Plumb, M. R., Malani, N., Male, F., Slaughter, A., Kessl, J. J., Shkriabai, N., Coward, E., Aiyer, S. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307157110 · Cited by 193
“To delineate the Brd3(1-726) segments (Fig.”
BackgroundResultInfluentialStructure-based modeling of the functional HIV-1 intasome and its inhibition
Krishnan, L., Li, X., Naraharisetty, H. L., Hare, S., Cherepanov, P., & Engelman, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002346107 · Cited by 191
“As observed in the PFV structure (26), the majority of HIV-1 IN residues contact the nontransferred DNA strand (Table S1).”
BackgroundInfluentialSelf-citationMultimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors
Kessl, J. J., Jena, N., Koh, Y., Taskent-Sezgin, H., Slaughter, A., Feng, L., de Silva, S., Wu, L., Le Grice, S. F. J., Engelman, A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.354373 · Cited by 182
“Integration proceeds through the SSC or intasome comprising a tetramer of integrase acting on the two ends of linear viral DNA substrate that we and others (6, 8, 30) have shown is resistant in vitro to chaotropic agents such as high concentrations of salt.”
BackgroundMethodInfluentialSelf-citationChrist, F., Shaw, S., Demeulemeester, J., Desimmie, B. A., Marchand, A., Butler, S., Smets, W., Chaltin, P., Westby, M., Debyser, Z., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00717-12 · Cited by 176
“This is in stark contrast with the uncompetitive mode of inhibition of INSTIs, which require prior binding and 3= processing of viral DNA ends (16, 18).”
ResultCrystal structure of the V(D)J recombinase RAG1–RAG2
Kim, M.-S., Lapkouski, M., Yang, W., & Gellert, M. (2015) · Nature · doi:10.1038/nature14174 · Cited by 172
Kowalinski, E., Zubieta, C., Wolkerstorfer, A., Szolar, O. H. J., Ruigrok, R. W. H., & Cusack, S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002831 · Cited by 169
Gogol-Döring, A., Ammar, I., Gupta, S., Bunse, M., Miskey, C., Chen, W., Uckert, W., Schulz, T. F., Izsvák, Z., & Ivics, Z. (2016) · Molecular Therapy · doi:10.1038/mt.2016.11 · Cited by 160
Self-citationDuBois, R. M., Slavish, P. J., Baughman, B. M., Yun, M., Bao, J., Webby, R. J., Webb, T. R., & White, S. W. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002830 · Cited by 159
“productive in terms of increasing potency [35,41,42], and Tyr24,”
Background3′‐Processing and strand transfer catalysed by retroviral integrase in crystallo
Hare, S., Maertens, G. N., & Cherepanov, P. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.118 · Cited by 153
“The UI was prepared and crystallized as described previously for the cleaved complex (Hare et al , 2010b) using oligonucleotides 5 0 -TGCGAAATTCCATGACAAT-3 0 and 5 0 -ATTGTCATGGAATTTCGCA-3 0 , mimicking the transferred and nonreactive strands, respectively.”
InfluentialSelf-citationBiomolecular modeling and simulation: a field coming of age
Schlick, T., Collepardo‐Guevara, R., Halvorsen, L., Jung, S. C., & Xiao, X. (2011) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583510000284 · Cited by 171
Nuclear landscape of HIV-1 infection and integration
Lušić, M., & Siliciano, R. F. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.162 · Cited by 201
Matreyek, K., & Engelman, A. (2013) · Viruses · doi:10.3390/v5102483 · Cited by 145
“The double-stranded reverse-transcribed viral DNA and a tetramer of IN protein form the heart of the PIC, as they comprise the intasome nucleoprotein complex that drives integration [56,57].”
BackgroundSelf-citationMetabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans
Castellino, S., Moss, L., Wagner, D. S., Borland, J., Song, I. H., Chen, S., Lou, Y., Min, S., Goljer, I., Culp, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00292-13 · Cited by 172
Billamboz, M., Bailly, F., Lion, C. J., Touati, N., Vezin, H., Calmels, C., Andréola, M., Christ, F., Debyser, Z., & Cotelle, P. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1014692 · Cited by 147
Gupta, S. S., Maetzig, T., Maertens, G. N., Sharif, A., Rothe, M., Weidner-Glunde, M., Galla, M., Schambach, A., Cherepanov, P., & Schulz, T. F. (2013) · Journal of Virology · doi:10.1128/jvi.01942-13 · Cited by 139
“To clone FLAG-tagged deletion constructs for MLV IN, IN fragments were PCR amplified from pQMLV-IN-FLAG plasmid using the following primer pairs: IN(110-409) ( NTD), SG1 and PC595; IN(160-409) ( CCD), SG2 and PC595; IN(1-278) ( CTD), PC594 and SG3; IN(160359) ( CCD CTD), SG2 and SG4.”
BackgroundMethodSelf-citationStructural basis for retroviral integration into nucleosomes
Maskell, D. P., Renault, L., Serrao, E., Lesbats, P., Matadeen, R., Hare, S., Lindemann, D., Engelman, A. N., Costa, A., & Cherepanov, P. (2015) · Nature · doi:10.1038/nature14495 · Cited by 138
Self-citationMolecular mechanisms of retroviral integration site selection
Kvaratskhelia, M., Sharma, A., Larue, R. C., Serrao, E., & Engelman, A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku769 · Cited by 135
“Highly conserved structural features of retroviral IN proteins include the catalytic triad of Asp, Asp and Glu (DDE) residues that coordinates a pair of essential Mg2+ ions during 3′ processing and strand transfer (32) and the Znbinding motif (HH-CC type) in the NTD that contributes to IN multimerization and DNA bindi…”
BackgroundSelf-citationZhao, A., Crutchley, R. D., Guduru, R. C., Ton, K., Lam, T., & Min, A. (2022) · Retrovirology · doi:10.1186/s12977-022-00608-1 · Cited by 156
“The first reaction is referred to as the “3’-processing” step and the second a “strand transfer” reaction [41, 42].”
BackgroundViral fitness cost prevents HIV-1 from evading dolutegravir drug pressure
Mésplède, T., Quashie, P. K., Osman, N., Han, Y.-S., Singhroy, D. N., Lie, Y., Petropoulos, C. J., Huang, W., & Wainberg, M. A. (2013) · Retrovirology · doi:10.1186/1742-4690-10-22 · Cited by 140
“Molecular modeling of HIV integrase and DTG docking were performed with the PFV lead template structures PDBID: 3S3M [25] and PDBID: 3L2S [33] as previously described [17].”
MethodStructure and function of retroviral integrase
Maertens, G. N., Engelman, A. N., & Cherepanov, P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00586-9 · Cited by 124
Self-citationMechanisms of DNA Transposition
Hickman, A. B., & Dyda, F. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0034-2014 · Cited by 157
“(A) An RNase H-like active site, based on structures of PFV intasomes (28, 94, 95).”
MethodLe Rouzic, E., Bonnard, D., Chasset, S., Bruneau, J.-M., Chevreuil, F., Le Strat, F., Nguyen, J., Beauvoir, R., Amadori, C., Brias, J., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-144 · Cited by 127
“The mode of INSTI action was elucidated in complex with a retroviral IN for which the entire 3D structure was defined [2].”
BackgroundHickman, A. B., & Dyda, F. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00003 · Cited by 145
Targets for Combating the Evolution of Acquired Antibiotic Resistance
Culyba, M. J., Mo, C. Y., & Kohli, R. M. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00109 · Cited by 150
Sheridan, R. P., Maiorov, V. N., Holloway, M. K., Cornell, W. D., & Gao, Y. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100312t · Cited by 126
Genetic barrier to resistance for dolutegravir.
Llibre, J. M., Pulido, F., García, F., Deltoro, M. G., Blanco, J. L., & Delgado, R. B. (2015) · PubMed · Cited by 152
Design, synthesis and antiviral activity of novel quinazolinones
Wang, Z., Wang, M., Yao, X. X., Li, Y., Tan, J., Wang, L., Qiao, W., Geng, Y., Liu, Y., & Wang, Q. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.04.010 · Cited by 122
“prototype foamy virus (PFV-1 IN) in complex with its cognate viral DNA and strand transfer inhibitors [14,15].”
BackgroundStructural insights into the retroviral DNA integration apparatus
Cherepanov, P., Maertens, G. N., & Hare, S. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2010.12.005 · Cited by 118
Self-citationStructure and inhibition of herpesvirus DNA packaging terminase nuclease domain
Nadal, M., Mas, P. J., Blanco, A. G., Arnan, C., Solà, M., Hart, D. J., & Coll, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007144107 · Cited by 118
“A recent structure of the prototype foamy virus integrase in complex with DNA and the inhibitor shows that raltegravir binds at the active site, directly coordinating the metal ions (38).”
BackgroundA supramolecular assembly mediates lentiviral DNA integration
Ballandras-Colas, A., Maskell, D. P., Serrao, E., Locke, J., Swuec, P., Jónsson, S. R., Kotecha, A., Cook, N. J., Pye, V. E., Taylor, I. A., et al. (2017) · Science · doi:10.1126/science.aah7002 · Cited by 107
“The CIC, analogous to those found in other retroviral systems (2, 4, 5), is located at the center of the assembly (Figs.”
BackgroundInfluentialSelf-citationRegulation of Histone Gene Expression in Budding Yeast
Eriksson, P. R., Ganguli, D., Nagarajavel, V, & Clark, D. J. (2012) · Genetics · doi:10.1534/genetics.112.140145 · Cited by 114
Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
Smith, S. J., Zhao, X. Z., Burke, T. R., & Hughes, S. H. (2018) · Retrovirology · doi:10.1186/s12977-018-0420-7 · Cited by 114
“However, it is the “left” side of the tricyclic ring system of BIC, which is the portion of the INSTI that is distal to the end of the viral DNA, and has an oxazepine ring which features a methylene bridge and lacks a methyl group, that appears to distinguish BIC from DTG.”
BackgroundInfluentialStructural basis of second-generation HIV integrase inhibitor action and viral resistance
Cook, N. J., Li, W., Berta, D., Badaoui, M., Ballandras-Colas, A., Nans, A., Kotecha, A., Rosta, E., Engelman, A. N., & Cherepanov, P. (2020) · Science · doi:10.1126/science.aay4919 · Cited by 108
Self-citationAntivirals Targeting Influenza A Virus
Das, K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300455c · Cited by 123
Structural biology of retroviral DNA integration
Li, X., Krishnan, L., Cherepanov, P., & Engelman, A. (2011) · Virology · doi:10.1016/j.virol.2010.12.008 · Cited by 126
“Although the HIV-1 NTD and CTD constructs were dimeric (Cai et al., 1997; Eijkelenboom et al., 1995; Eijkelenboom et al., 1999; Lodi et al., 1995), the dimer interfaces have not been observed in later crystal structures (Chen et al., 2000a; Chen et al., 2000b; Hare et al., 2010a; Yang et al., 2000).”
BackgroundResultInfluentialSelf-citationThe LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy
Christ, F., & Debyser, Z. (2012) · Virology · doi:10.1016/j.virol.2012.09.033 · Cited by 131
Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs
Smith, S. J., Zhao, X. Z., Passos, D. O., Lyumkis, D., Burke, T. R., & Hughes, S. H. (2021) · Viruses · doi:10.3390/v13020205 · Cited by 131
“Recent structural work using both HIV-1 and SIV intasomes (see these reviews for additional information about recent structural analyses [139,140]) has confirmed and extended the previous structural studies performed with PFV IN [28,29], and has already helped in the design of new INSTIs.”
BackgroundMethodInfluentialAbram, M. E., Hluhanich, R. M., Goodman, D. D., Andreatta, K. N., Margot, N., Ye, L., Niedziela‐Majka, A., Barnes, T. L., Novikov, N. Y., Chen, X., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02568-12 · Cited by 121
“First, a model of WT HIV-1 IN was created by substitution of the corresponding amino acid residues into the published structure of PFV IN (29).”
BackgroundMethodInfluentialStructural basis for strand-transfer inhibitor binding to HIV intasomes
Passos, D. O., Li, M., Jóźwik, I. K., Zhao, X. Z., Santos-Martins, D., Yang, R., Smith, S. J., Jeon, Y., Forli, S., Hughes, S. H., et al. (2020) · Science · doi:10.1126/science.aay8015 · Cited by 106
Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection
Menéndez‐Arias, L., & Álvarez, M. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.12.001 · Cited by 118
HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection
Bangham, C. R. M., Cook, L. B. M., & Melamed, A. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.11.003 · Cited by 119
Crépin, T., Dias, A., Palencia, A., Swale, C., Cusack, S., & Ruigrok, R. W. H. (2010) · Journal of Virology · doi:10.1128/jvi.00995-10 · Cited by 102
Inhibiting the HIV Integration Process: Past, Present, and the Future
Santo, R. D. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400674a · Cited by 112
Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor
Fenwick, C., Amad, M., Bailey, M. D., Bethell, R., Bös, M., Bonneau, P., Cordingley, M., Coulombe, R., Duan, J., Edwards, P., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02719-13 · Cited by 99
Resistance to Integrase Inhibitors
Métifiot, M., Marchand, C., Maddali, K., & Pommier, Y. G. (2010) · Viruses · doi:10.3390/v2071347 · Cited by 218
“Also, the flexible loop appears involved in RAL and EVG binding, highlighting a crucial role of the flexible loop in both IN activity and drug resistance [32].”
BackgroundInfluentialCryo-EM reveals a novel octameric integrase structure for betaretroviral intasome function
Ballandras-Colas, A., Brown, M., Cook, N. J., Dewdney, T. G., Demeler, B., Cherepanov, P., Lyumkis, D., & Engelman, A. N. (2016) · Nature · doi:10.1038/nature16955 · Cited by 98
Self-citationRetroviral Integrase Proteins and HIV-1 DNA Integration
Krishnan, L., & Engelman, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.397760 · Cited by 135
“X-ray crystal structures of functional PFV intasomes have yielded unprecedented details on the mechanism of retroviral DNA integration (13, 18, 26).”
BackgroundInfluentialSelf-citationFoamy Virus Biology and Its Application for Vector Development
Lindemann, D., & Rethwilm, A. (2011) · Viruses · doi:10.3390/v3050561 · Cited by 114
“The FV IN subunit has attracted a lot of attention recently, as it was the first retroviral IN for which a crystal structure of the full-length subunit in complex with its viral substrate was obtained [96].”
BackgroundHarshey, R. M. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0007-2014 · Cited by 108
“Crystal structures of the HIV-related prototype foamy virus (PFV) retroviral integrase assemblies (intasomes), whose phosphotransfer mechanism is similar to Mu, validate the SN2 mechanism (21, 22, 23).”
BackgroundCrystal structure of the Rous sarcoma virus intasome
Yin, Z., Shi, K., Banerjee, S., Pandey, K. K., Bera, S., Grandgenett, D. P., & Aihara, H. (2016) · Nature · doi:10.1038/nature16950 · Cited by 95
Retroviral Integrase Structure and DNA Recombination Mechanism
Engelman, A., & Cherepanov, P. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0024-2014 · Cited by 94
“Overlaying drug-bound structures with those of the metal-bound SSC and TCC revealed additional insight into the function of INSTI co-planar oxygen atoms.”
BackgroundInfluentialSelf-citationHost factors for retroviral integration site selection
Debyser, Z., Christ, F., Rijck, J. D., & Gijsbers, R. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.12.001 · Cited by 102
Bar-Magen, T., Sloan, R. D., Donahue, D. A., Kuhl, B. D., Zabeida, A., Xu, H., Oliveira, M., Hazuda, D. J., & Wainberg, M. A. (2010) · Journal of Virology · doi:10.1128/jvi.01164-10 · Cited by 91
“Recent cocrystal structures of RAL and EVG with the intasome of prototype foamy virus (PFV) have confirmed the interaction of the pharmacophores of these compounds with two divalent metals at the active site as well as an interaction between the benzyl group and the bound viral DNA end (16).”
BackgroundCellular and molecular mechanisms of HIV-1 integration targeting
Engelman, A., & Singh, P. K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2772-5 · Cited by 113
“The number of integrase protomers that comprise the intasome differs among the different retroviruses, from a minimum of four for the spumaviruses [6] to as many as 16 molecules for the lentiviruses [7, 8] (see [9] for a recent review).”
BackgroundSelf-citationFeng, L., Sharma, A., Slaughter, A., Jena, N., Koh, Y., Shkriabai, N., Larue, R. C., Patel, P. A., Mitsuya, H., Kessl, J. J., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.443390 · Cited by 89
“Whereas the IN strand transfer inhibitors specifically interact with the IN-viral DNA complex (27), ALLINIs target a clinically unexploited IN dimer interface at the LEDGF/p75binding site.”
BackgroundSelf-citationMurray, J. M., Kelleher, A. D., & Cooper, D. A. (2011) · Journal of Virology · doi:10.1128/jvi.05095-11 · Cited by 93
“This has been observed in vitro where the NNRTI nevirapine was more successful in terminating shorter minus-strand DNA products than the NRTI zidovudine (AZT) (33).”
BackgroundInfluentialIdentification of Influenza Endonuclease Inhibitors Using a Novel Fluorescence Polarization Assay
Baughman, B. M., Slavish, P. J., DuBois, R. M., Boyd, V. A., White, S. W., & Webb, T. R. (2012) · ACS Chemical Biology · doi:10.1021/cb200439z · Cited by 87
Single helically folded aromatic oligoamides that mimic the charge surface of double-stranded B-DNA
Ziach, K., Chollet, C., Parissi, V., Prabhakaran, P., Marchivie, M., Corvaglia, V., Bose, P. P., Laxmi‐Reddy, K., Godde, F., Schmitter, J., et al. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0018-7 · Cited by 95
LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 – 2014)
Demeulemeester, J., Chaltin, P., Marchand, A., Maeyer, M. D., Debyser, Z., & Christ, F. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.898753 · Cited by 99
“succeeded in crystallizing the related prototype foamy virus IN ( genus Spumavirinae) in a functional complex with synthetic long terminal repeat (LTR) DNA ends, known as the intasome [10].”
BackgroundAllosteric Inhibition of Human Immunodeficiency Virus Integrase
Gupta, K., Brady, T., Dyer, B. M., Malani, N., Hwang, Y., Male, F., Nolte, R. T., Wang, L., Velthuisen, E., Jeffrey, J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551119 · Cited by 81
The Molecular Biology of HIV Integrase
Craigie, R. (2012) · Future Virology · doi:10.2217/fvl.12.56 · Cited by 108
“The N-terminal domain, C-terminal domain and the extra N-terminal extension domain of the outer PFV integrase subunits are disordered in the current structures.”
BackgroundInfluentialElvitegravir overcomes resistance to raltegravir induced by integrase mutation Y143
Métifiot, M., Vandegraaff, N., Maddali, K., Naumova, A., Zhang, X., Rhodes, D., Marchand, C., & Pommier, Y. G. (2011) · AIDS · doi:10.1097/qad.0b013e3283473599 · Cited by 83
“Integrase corresponds to HIV-1 integrase residue Y143 implicated in RAL res EVG are in magenta with nitrogen atoms in blue, oxygens in red, complex with a substrate mimicking the viral DNA end after its 30-processing (30-P) by integrase, providing the first three-dimensional structure of an active integrase active sit…”
BackgroundMethodInhibition of human endogenous retrovirus-K by antiretroviral drugs
Tyagi, R., Li, W., Parades, D., Bianchet, M. A., & Nath, A. (2017) · Retrovirology · doi:10.1186/s12977-017-0347-4 · Cited by 78
“Glyceraldehyde 3-phosphotate dehydrogenase (GAPDH) was used as internal control and titers were expressed as fold change. iii Western blot of VSV-G protein to show that VSV-G protein is incorporated into the HERV-K viral particles. b–d Hela cells were infected with 80 pg of VSV-G pseudotyped HERV-K virus and treated w…”
InfluentialClinical Management of HIV Drug Resistance
Cortez, K. J., & Maldarelli, F. M. (2011) · Viruses · doi:10.3390/v3040347 · Cited by 78
“Structure is from Cherapenov and coworkers [128] and rendered in RASMOL [100,101].”
BackgroundMultifaceted HIV integrase functionalities and therapeutic strategies for their inhibition
Engelman, A. N. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.006901 · Cited by 78
“The overall conformation of the PFV intasome structure changes little as the complex morphs from the SSC to the strand transfer complex and promotes IN 3 processing and strand transfer activities (16, 35, 37, 43, 44).”
BackgroundInfluentialSelf-citationMariner and the ITm Superfamily of Transposons
Tellier, M., Bouuaert, C. C., & Chalmers, R. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0033-2014 · Cited by 86
“The retroviral integrase has provided the most complete set, with structures representing pre-and postcleavage intermediates and target complexes (24, 99, 100).”
BackgroundPolymyxins and quinazolines are LSD1/KDM1A inhibitors with unusual structural features
Speranzini, V., Rotili, D., Ciossani, G., Pilotto, S., Marrocco, B., Forgione, M., Lucidi, A., Forneris, F., Mehdipour, P., Velankar, S. S., et al. (2016) · Science Advances · doi:10.1126/sciadv.1601017 · Cited by 79
“2016; 2 : e1601017 9 September 2016 (23, 24).”
Novel therapeutic strategies targeting HIV integrase
Quashie, P. K., Sloan, R. D., & Wainberg, M. A. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-34 · Cited by 74
“In 2010, the fulllength structures of IN from the prototype foamy virus (PFV) in complex with LTR mimetics were published [83].”
BackgroundAllosteric inhibition of HIV-1 integrase activity
Engelman, A., Kessl, J. J., & Kvaratskhelia, M. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.04.010 · Cited by 75
Self-citationLansdon, E. B., Liu, Q., Leavitt, S. A., Balakrishnan, M., Perry, J. K., Lancaster-Moyer, C., Kutty, N., Liu, X., Squires, N. H., Watkins, W. J., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01594-10 · Cited by 79
“ions in the active site of integrase (21).”
BackgroundWielens, J., Headey, S. J., Rhodes, D. I., Mulder, R. J., Dolezal, O., Deadman, J. J., Newman, J. M., Chalmers, D. K., Parker, M. W., Peat, T. S., et al. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112465979 · Cited by 78
“Experiments were normalized to a R max of 100 RU using a normalization formula of (MW con- trol /MW sample ) · (100/R max , control).22 Hits that generated an SPR signal for IN that was two times larger than the response on the reference (AMA1) protein were considered as selective binders of IN. Hits were further rank…”
BackgroundInfluentialXue, W., Jin, X., Ning, L., Wang, M., Liu, H., & Yao, X. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci300541c · Cited by 74
Métifiot, M., Marchand, C., & Pommier, Y. G. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-405880-4.00003-2 · Cited by 104
“89Twenty Years of HIV Integrase Inhibitor Research RAL, EVG, and DTG have all been cocrystallized in the PFV IN active site (Hare et al., 2010, 2011).”
BackgroundResistance to HIV-1 integrase inhibitors: A structural perspective
Mouscadet, J. F., Delelis, O., Marcelin, A., & Tchertanov, L. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.05.001 · Cited by 81
“6e and 7e) (Hare et al., 2010). he mode of binding was similar for the INSTIs, involving an nduced-fit mechanism and a position close to that identified ith the modeling induced-fit approach in terms of the mode f interaction with the metal cofactor (Hare et al., 2010).”
BackgroundInfluentialRecent Advances of Pyridinone in Medicinal Chemistry
Lin, S., Liu, C., Zhao, X., Han, X., Li, X., Ye, Y., & Li, Z. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.869860 · Cited by 74
“Raltegravir, elvitegravir, and dolutegravir are representative marketed HIV-1 integrase strand transfer inhibitors (InSTIs) for their proven efficacy and excellent tolerability (Hare et al., 2010; Smith et al., 2020).”
BackgroundThe role of integration and clonal expansion in HIV infection: live long and prosper
Anderson, E. M., & Maldarelli, F. M. (2018) · Retrovirology · doi:10.1186/s12977-018-0448-8 · Cited by 83
Demeulemeester, J., De Rijck, J., Gijsbers, R., & Debyser, Z. (2015) · BioEssays · doi:10.1002/bies.201500051 · Cited by 71
“X-ray crystal structures of the spumaviral Prototype Foamy Virus (PFV) intasome complex have boosted our understanding of the retroviral integration machinery [9, 10].”
BackgroundLesbats, P., Botbol, Y., Chevereau, G., Vaillant, C., Calmels, C., Arneodo, A., Andreola, M.-L., Lavigne, M., & Parissi, V. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001280 · Cited by 71
“containing a tetrameric IN bound to two viral ends would require at least local remodeling for two-end concerted integration ([53]”
BackgroundTang, J. Y., Maddali, K., Dreis, C. D., Sham, Y. Y., Vince, R., Pommier, Y. G., & Wang, Z. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1002162 · Cited by 70
Shen, L., Rabi, S. A., Sedaghat, A. R., Shan, L., Lai, J., Xing, S., & Siliciano, R. F. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002304 · Cited by 68
“For the InSTIs, the inhibited process is performed by precisely onemolecular complex per infected cell, consisting of an integrase tetramer bound to the ends of the viral genome (26, 27).”
Moving DNA around: DNA transposition and retroviral integration
Montaño, S. P., & Rice, P. A. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.03.004 · Cited by 70
Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase
Gupta, K., Turkki, V., Sherrill-Mix, S., Hwang, Y., Eilers, G., Taylor, L., McDanal, C., Wang, P., Temelkoff, D., Nolte, R. T., et al. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002584 · Cited by 68
Esposito, F., & Tramontano, E. (2014) · Antiviral Chemistry and Chemotherapy · doi:10.3851/imp2690 · Cited by 68
Quashie, P. K., Mésplède, T., Han, Y.-S., Veres, T., Osman, N., Hassounah, S. A., Sloan, R. D., Xu, H., & Wainberg, M. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01835-13 · Cited by 69
“7 and 8) were created using the I-TASSER server (38, 51) with the recently published structures of PFV integrase as lead modeling templates (31).”
BackgroundMethodInfluential
Metadata
- Authors
- Hare, S., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P.
- Affiliations
- Imperial College London (GB)
- The University of Queensland (AU)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Cherepanov, Peter
- Venue
- Nature
- Published
- 2010-01-31
- Volume
- 464
- Issue
- 7286
- Pages
- 232-236
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2837123
- OpenAlex
- W2025344323
- Cited by
- 678
- References
- 50
- Citations by year
- 2026: 14 · 2025: 10 · 2024: 15 · 2023: 21 · 2022: 19 · 2021: 31 · 2020: 29 · 2019: 38 · 2018: 33 · 2017: 31 · 2016: 43 · 2015: 53 · 2014: 49 · 2013: 68 · 2012: 79
- FWCI
- 60.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Diamond Light Source
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (R01AI070042, P30AI060354)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- retroviral integrase, intasome, DNA strand transfer, HIV-1 integrase, integrase strand transfer inhibitors, raltegravir, elvitegravir, antiretroviral drug development, viral DNA integration, protein-DNA interactions
- MeSH terms
- DNA, Viral, Models, Molecular, Retroviridae, HIV-1, Protein Structure, Tertiary, Integrases, Catalytic Domain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.